Literature DB >> 3152773

Intravascular survival of leukemic cells labeled with indium-111-oxine.

T Uchida1, Y Takagi, S Matsuda, T Ishibashi, H Kimura, S Kariyone.   

Abstract

A method for labeling leukemic cells in vitro with 111In-oxine is described. Intravascular survival data and organ distribution of 111In-oxine-labeled leukemic cells in patients with acute leukemia are presented. No evidence of diminished cell viability or significant elution of the label could be found by the in vitro studies. Disappearance curves of 111In-labeled leukemic cell radioactivity in the circulation were a single exponential with average T1/2 value of 15.3 +/- 2.5 hr (mean +/- SEM), which was found to be prolonged when compared with the results of 4 hematologically normal subjects (7.0 +/- 0.8) and those of previously reported DF32P studies. Migratory patterns of the labeled leukemic cells, obtained by a scintillation camera, demonstrated sequestration in the lungs 5 min after the infusion, and thereafter, the uptake into the spleen and liver gradually increased. We believe that the properties of 111In-oxine might overcome many of the difficulties of studying leukemic cell kinetics with cells labeled with tritiated thymidine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3152773     DOI: 10.1007/bf03164548

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  23 in total

1.  LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.

Authors:  J W ATHENS; S O RAAB; O P HAAB; D R BOGGS; H ASHENBRUCKER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  LEUKOKINETIC STUDIES. II. A METHOD FOR LABELING GRANULOCYTES IN VITRO WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP).

Authors:  A M Mauer; J W Athens; H Ashenbrucker; G E Cartwright; M M Wintrobe
Journal:  J Clin Invest       Date:  1960-09       Impact factor: 14.808

3.  The radiolabeling of lymphocytes and tumor cells with 111indium.

Authors:  P Frost; J Smith; H Frost
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Characteristics of cell proliferation in four patients with untreated acute leukemia.

Authors:  A M Mauer; V Fisher
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

6.  Investigations of leucocyte kinetics in normal and leukaemic individuals by means of scintillation counting.

Authors:  S Perry; J H Moxley
Journal:  Nature       Date:  1966-02-26       Impact factor: 49.962

7.  Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia.

Authors:  M D Minden; R N Buick; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

8.  Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.

Authors:  B Clarkson; T Ohkita; K Ota; J Fried
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  Studies of the kinetics of indium-111-labeled granulocytes.

Authors:  B J Weiblen; L Forstrom; J McCullough
Journal:  J Lab Clin Med       Date:  1979-08

10.  The migratory properties of indium-111 oxine labelled lymphocytes in patients with chronic lymphocytic leukaemia.

Authors:  J Wagstaff; C Gibson; N Thatcher; D Crowther
Journal:  Br J Haematol       Date:  1981-10       Impact factor: 6.998

View more
  1 in total

1.  Distribution of intrasplenically injected colon cancer cells following pneumoperitoneum in mice.

Authors:  H Ishida; H Nakada; I Takeuchi; M Yokoyama; T Okita; D Hashimoto; M Hosono; T Mori
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.